LS
Therapeutic Areas
OncoSil Medical Pipeline
| Drug | Indication | Phase |
|---|---|---|
| OncoSil™ (PANCOSIL) | Locally advanced unresectable pancreatic cancer | Phase 2 |
Leadership Team at OncoSil Medical
NL
Nigel Lange
Chief Executive Officer and Managing Director
HT
Henk Tissing
Director, Global Head of Clinical Affairs
SS
Shelley Steyn
Chief Financial Officer
RD
Renzo DiCarlo
Head of Transformation
PJ
Professor Jon Bell
Chief Medical Officer
DT
David Turner
Global Head of Medical Affairs
TD
Thomas Duthy
Non‑Executive Chairman